Characterization of the usage of the serine metabolic network in human cancer
about
Mathematical models of cancer metabolismRRmix: A method for simultaneous batch effect correction and analysis of metabolomics data in the absence of internal standards.The Warburg Effect: How Does it Benefit Cancer Cells?Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by 13C NMR Spectroscopy of Perfused Tumor CellsMetabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.(13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism.Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow.Formate supplementation enhances folate-dependent nucleotide biosynthesis and prevents spina bifida in a mouse model of folic acid-resistant neural tube defectsIntegrative modelling of tumour DNA methylation quantifies the contribution of metabolismMitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation.NF-Y activates genes of metabolic pathways altered in cancer cells.One-carbon metabolism in cancer.LKB1 loss links serine metabolism to DNA methylation and tumorigenesis.Metabolomics: A Primer.Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype.mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle.Metabolic interactions with cancer epigenetics.One-Carbon Metabolism in Health and Disease.Understanding metabolism with flux analysis: From theory to application.The importance of accurately correcting for the natural abundance of stable isotopes.Metabolism shapes the tumor microenvironment.New Challenges to Study Heterogeneity in Cancer Redox Metabolism.Context dependent utilization of serine in cancer.Molecular features that predict the response to antimetabolite chemotherapies.Systematic analyses of glutamine and glutamate metabolisms across different cancer types.Mitochondrial diseases: the contribution of organelle stress responses to pathology.A combined NMR- and HPLC-MS/MS-based metabolomics to evaluate the metabolic perturbations and subacute toxic effects of endosulfan on mice.Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.Effect of dietary restriction and subsequent re-alimentation on the transcriptional profile of bovine jejunal epithelium.Biochemistry: A toxin that fuels metabolismShift from stochastic to spatially-ordered expression of serine-glycine synthesis enzymes in 3D microtumors.Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells
P2860
Q26772067-E1032EBF-CCDD-4EAD-8EED-E466F6AB1C36Q33852969-B2740AC1-FA9A-490F-9934-D5B776048B8DQ34509467-11A39FFC-D160-42B9-84EC-D4EDE95B125CQ36419289-67A1A42E-6907-4EF6-82DA-6DA3C7BE99C0Q36650340-FDA56E6B-D97A-4AE5-B88C-BF3727086E24Q36882685-54F5F12E-E3DA-439C-93F9-6D68AED6BA57Q37004918-5CC5A73A-CD41-43D6-8238-A63A138BAA59Q37008970-BB06CC50-5F71-4795-8F9E-0E23D697E4FFQ37009382-598472D0-62FA-41E0-8FA1-13CACF12A9CDQ37518974-AE44CEDA-F425-4083-9C8B-F96E5E2682DCQ37671993-A7D762EB-1680-45E4-B24E-5FF892510985Q38294889-15BC6669-FAD6-4E11-9057-19ABFDC9A7C2Q38687639-0CC114ED-DBF9-4209-9AAE-E92B6F3E4866Q38733837-6E6AF841-A481-4800-9301-8AC5F8059D6AQ38757603-F019B98C-C68E-4417-80A4-E62857C58CB7Q38874166-EAE1F155-56F0-4A8D-8EA3-469A8BD13423Q38910153-FDEFB434-6441-4E18-89BE-F62A6A6CB54EQ38952577-F5DD2982-AD6F-45CC-B74D-04EE145F02D4Q38957946-721F0145-C2E2-43FE-8707-E2A7B8E5497BQ38964375-528117C1-3793-4171-A549-5EB69685784CQ39042667-D79877B2-FC25-4537-B5E7-A566D739F373Q39367096-F3BFD055-3BC8-4AC3-94CE-70AEEDABE521Q39458558-E467754A-E1A7-4B44-A8FD-A51275302180Q40342051-703C2639-4841-412E-B9AD-28A5B6BF06FBQ42281145-3DECC9FC-D720-4BA9-9712-B4ECD6EDFAD2Q47155640-2498A053-1775-410E-920F-875059525E72Q47974129-4878518B-6408-45B2-B56E-AD1C8478112FQ47983266-135E473C-6121-42D5-A102-1A4077841C00Q48091849-3107F991-D9F2-4AEE-BA80-1FCD6EE779F7Q52648796-AE141296-3844-4E32-BBBB-C11ADA93032CQ53608408-13A84771-F843-4957-B369-D07DFA920DA3Q55426297-2B08F6DF-D95C-4639-97AA-607B3118D014Q58747454-28BA62AF-206F-4F23-B3AA-5EC5B963714F
P2860
Characterization of the usage of the serine metabolic network in human cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of the usage of the serine metabolic network in human cancer
@ast
Characterization of the usage of the serine metabolic network in human cancer
@en
type
label
Characterization of the usage of the serine metabolic network in human cancer
@ast
Characterization of the usage of the serine metabolic network in human cancer
@en
prefLabel
Characterization of the usage of the serine metabolic network in human cancer
@ast
Characterization of the usage of the serine metabolic network in human cancer
@en
P2093
P2860
P1433
P1476
Characterization of the usage of the serine metabolic network in human cancer
@en
P2093
Alexander A Shestov
Mahya Mehrmohamadi
Xiaojing Liu
P2860
P304
P356
10.1016/J.CELREP.2014.10.026
P577
2014-11-06T00:00:00Z